Codeine Withdrawn Phase 4 Trials for Sickle Cell Disorders Basic Science

IndicationsStatusPurposePhase
WithdrawnBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT00513864Assessment of Opioid Analgesia in Sickle Cell